Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide–Protein Conjugate Vaccines | Zendy

Carol J. Baker | Zendy; Lawrence C. Paoletti | Zendy; Marcia A. Rench | Zendy; HildeKari Guttormsen | Zendy; Morven S. Edwards | Zendy; Dennis L. Kasper | Zendy

Open Access

Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide–Protein Conjugate Vaccines

Author(s) -

Carol J. Baker,

Lawrence C. Paoletti,

Marcia A. Rench,

HildeKari Guttormsen,

Morven S. Edwards,

Dennis L. Kasper

Publication year - 2004

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/382193

Subject(s) - conjugate vaccine , toxoid , antibody , immunology , immune system , immunoglobulin g , group b , conjugate , medicine , isotype , vaccination , pneumococcal conjugate vaccine , immunogenicity , microbiology and biotechnology , immunization , biology , streptococcus pneumoniae , antibiotics , monoclonal antibody , mathematical analysis , mathematics

Infections caused by group B streptococcal (GBS) type V are increasingly common. Capsular polysaccharide (CPS)-protein conjugate GBS vaccines are immunogenic in healthy adults, but type V vaccines have not previously been tested.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research